Question 1

IMVT vs JNJ: which stock scores better overall?

Accepted Answer

Based on Q·Score, Johnson & Johnson (JNJ) scores 7.1/10 versus Immunovant, Inc. (IMVT) at 5.1/10. The Q·Score measures five dimensions: Quality, Value, Growth, Safety, and Momentum. For informational purposes only — not financial advice.

Question 2

Which has better revenue growth: IMVT or JNJ?

Accepted Answer

Immunovant, Inc. (IMVT) scores higher on Growth (5.6/10 vs 5.1/10). Immunovant, Inc. reports revenue growth while Johnson & Johnson reports (9.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Question 3

Is IMVT or JNJ more attractively valued?

Accepted Answer

Johnson & Johnson (JNJ) scores higher on Value (7.3/10 vs 5.7/10). Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

Question 4

What do analysts say about IMVT vs JNJ?

Accepted Answer

There are 17 analysts covering IMVT with a consensus price target of $40.29, and 24 analysts covering JNJ with a consensus target of $252.42. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Question 5

Which is more profitable: IMVT or JNJ?

Accepted Answer

Johnson & Johnson (JNJ) scores higher on Quality (9.3/10 vs 1.6/10). Net profit margin: IMVT at 0.0%, JNJ at 21.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Question 6

Which has stronger financial health: IMVT or JNJ?

Accepted Answer

Immunovant, Inc. (IMVT) scores higher on Financial Health (6.7/10 vs 6.5/10). Market beta: IMVT at 0.67, JNJ at 0.33. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

Question 7

What are the market caps of IMVT and JNJ?

Accepted Answer

Immunovant, Inc. (IMVT) has a market capitalisation of $5.5B, while Johnson & Johnson (JNJ) has a market cap of $546.9B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Question 8

Do IMVT or JNJ pay dividends?

Accepted Answer

IMVT does not currently pay a dividend, while JNJ pays a dividend yield of 2.36%. Dividend yields fluctuate with share price and company payout decisions.

Immunovant, Inc. vs Johnson & Johnson — Stock Comparison

Q·Score Breakdown

Analyst Consensus

Fundamentals